Mayne Pharma has denied US drug maker Cosette’s claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.
A court has heard US drug maker Cosette may amend its case to accuse Adelaide’s Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.
Mayne Pharma has said it may seek to shut out US drug maker Cosette’s expert evidence in proceedings over the purported termination of their $672 million merger.
A judge has stayed engineering firm Clough’s $54 million cross-claim against its former joint venture partner on the EnergyConnect transmission project, Elecnor, saying the claim must be sent to arbitration.
Insurer Marsh has fired off a cross-claim against Swiss bank UBS in several cases brought over Greensill’s $1.7 billion collapse.
Australia’s largest brick manufacturer Brickworks has settled a competition case brought against rival BGC, a company founded by billionaire Len Buckeridge.
Australia’s largest brick manufacturer Brickworks has dropped a central claim in its competition lawsuit against a rival founded by billionaire Len Buckeridge.
A judge has ruled that two Deloitte partners can act as administrators for embattled wealth manager Keystone, replacing two voluntary administrators from KordaMentha, despite an alleged risk of conflict due to past work for the company.
A breakdown in the relationship of two high-flying friends — former senior ANZ executive David Carr and Barclays top banker Ivan Ritossa — was not a reason to order the winding up of the pair’s property investment trust, a court has found.
The Australian Communications and Media Authority says a coding error on a dormant website that went undetected for four years was behind a massive data breach that exposed the information of close to 10 million Optus customers, with the regulator saying the hack was “not highly sophisticated”.